BMO Capital Starts MyoKardia (MYOK) at Outperform

February 21, 2019 5:28 PM EST Send to a Friend
BMO Capital analyst George Farmer initiates coverage on MyoKardia (NASDAQ: MYOK) with a Outperform rating and a price target of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login